av/united-therapeutics--big.svg

NASDAQ:UTHR

United Therapeutics Corporation

  • Stock

USD

Last Close

360.22

30/08 20:00

Market Cap

14.61B

Beta: 0.60

Volume Today

392.55K

Avg: 596.50K

PE Ratio

11.12

PFCF: 13.12

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
42.51M
-
57.34M
34.90%
74.13M
29.28%
90.67M
22.31%
103.95M
14.65%
104.45M
0.48%
97.20M
6.94%
89.95M
7.46%
90.15M
0.22%
97.90M
8.60%
106.90M
9.19%
average payables
8.46M
-
6.85M
18.97%
7.25M
5.79%
7.80M
7.62%
8.25M
5.76%
15.75M
90.91%
16.50M
4.76%
7M
57.58%
3.95M
43.57%
3.95M
0%
4.85M
22.78%
average receivables
121.46M
-
144.29M
18.80%
177.56M
23.05%
203.66M
14.70%
255.80M
25.60%
236.40M
7.58%
163.55M
30.82%
154.40M
5.59%
178.05M
15.32%
209.55M
17.69%
249.65M
19.14%
book value per share
26.05
-
26.27
0.86%
34.77
32.38%
42.52
22.26%
47.77
12.35%
64.11
34.20%
63.48
0.98%
76.81
21.01%
88.17
14.78%
105.42
19.56%
120.42
14.23%
capex per share
-0.64
-
-0.98
54.53%
-1.08
9.93%
-0.99
8.88%
-1.96
98.86%
-4.24
116.13%
-1.91
54.92%
-1.34
29.79%
-2.69
100.53%
-3.05
13.39%
-4.64
51.97%
capex to depreciation
-1.02
-
-1.47
44.12%
-1.51
2.80%
-1.37
9.61%
-2.78
103.64%
-5.14
84.51%
-1.82
64.50%
-1.19
34.83%
-2.42
103.71%
-2.71
11.76%
-4.33
60.07%
capex to operating cash flow
-0.08
-
-0.13
77.96%
-0.13
2.58%
-0.07
48.40%
-0.18
171.13%
-0.24
30.17%
0.41
271.02%
-0.08
119.37%
-0.20
157.34%
-0.17
14.35%
-0.24
36.21%
capex to revenue
-0.03
-
-0.04
28.87%
-0.03
7.73%
-0.03
20.46%
-0.05
85.12%
-0.11
126.47%
-0.06
49.00%
-0.04
30.80%
-0.07
79.27%
-0.07
0.02%
-0.10
38.09%
cash per share
13.75
-
14.44
5.00%
20.73
43.61%
23.99
15.71%
21.08
12.14%
32.55
54.43%
33.92
4.23%
41.52
22.38%
43
3.57%
62.39
45.09%
60.24
3.44%
days of inventory on hand
132.94
-
194.06
45.98%
430.02
121.60%
502.06
16.75%
372.60
25.79%
185.53
50.21%
289.89
56.25%
292.07
0.75%
279.49
4.31%
253.78
9.20%
158.47
37.56%
days payables outstanding
18.67
-
20.28
8.62%
39.66
95.56%
40.67
2.53%
29.01
28.67%
42.43
46.29%
30.73
27.59%
13.84
54.95%
11.32
18.21%
10.20
9.90%
7.94
22.19%
days sales outstanding
41.27
-
45.97
11.39%
48.02
4.45%
48.97
1.98%
62.85
28.35%
39.40
37.32%
38.14
3.18%
38.73
1.54%
43.03
11.09%
41.55
3.45%
43.74
5.27%
debt to assets
0.14
-
0.07
51.04%
0.00
96.33%
0.09
-
0.07
15.34%
0.22
195.48%
0.17
20.19%
0.15
10.72%
0.13
14.48%
0.10
26.20%
debt to equity
0.22
-
0.10
54.45%
0.00
96.63%
0.12
-
0.09
24.63%
0.31
241.00%
0.24
22.93%
0.20
14.24%
0.17
17.47%
0.12
29.87%
dividend yield
0.00
-
0.03
548.67%
0.01
82.10%
0.00
77.54%
0.00
-
0.00
34.08%
0.01
-
earnings yield
0.03
-
0.05
76.84%
0.09
65.93%
0.11
25.59%
0.06
43.49%
0.12
93.75%
-0.03
121.78%
0.08
383.27%
0.05
36.09%
0.06
17.21%
0.09
56.77%
enterprise value
5.67B
-
5.97B
5.24%
6.38B
6.88%
5.26B
17.54%
6.05B
15.13%
4.32B
28.68%
3.97B
8.07%
6.77B
70.56%
9.61B
41.90%
12.49B
30.03%
10.42B
16.58%
enterprise value over ebitda
19.09
-
10.99
42.42%
9.12
17.03%
4.94
45.82%
5.83
18.01%
5.23
10.40%
-32.86
728.82%
10.08
130.68%
15.63
54.99%
12.69
18.82%
7.51
40.77%
ev to operating cash flow
13.33
-
16.80
25.98%
16.66
0.80%
8.17
50.96%
12.77
56.25%
5.55
56.55%
-19.21
446.36%
8.96
146.63%
16.06
79.26%
15.57
3.08%
10.66
31.55%
ev to sales
5.08
-
4.63
8.77%
4.35
6.04%
3.29
24.40%
3.51
6.68%
2.65
24.41%
2.74
3.29%
4.56
66.59%
5.70
24.88%
6.45
13.18%
4.48
30.60%
free cash flow per share
7.86
-
6.39
18.66%
7.24
13.29%
13.71
89.37%
8.82
35.69%
13.66
54.89%
-6.63
148.54%
15.76
337.72%
10.63
32.52%
14.59
37.19%
15.04
3.12%
free cash flow yield
0.07
-
0.05
28.97%
0.05
6.33%
0.10
106.78%
0.06
37.65%
0.13
110.43%
-0.08
160.01%
0.10
237.94%
0.05
52.59%
0.05
6.60%
0.07
30.42%
graham net net
0.48
-
4.81
909.34%
12.05
150.33%
18.23
51.26%
9.69
46.81%
22.66
133.75%
11.72
48.30%
17.57
49.95%
20.41
16.18%
39.72
94.60%
41.79
5.22%
graham number
45.20
-
64.59
42.91%
105.28
62.99%
124.85
18.59%
101.03
19.08%
139.77
38.34%
58.38
58.24%
141.88
143.05%
144.99
2.19%
194.72
34.30%
231.70
18.99%
income quality
2.44
-
1.04
57.12%
0.59
43.77%
0.90
53.53%
1.13
25.83%
1.32
16.43%
1.98
49.65%
1.47
25.75%
1.26
14.35%
1.10
12.24%
0.99
10.00%
intangibles to total assets
0.01
-
0.02
131.25%
0.01
16.92%
0.01
11.88%
0.02
8.96%
0.05
217.12%
0.04
19.45%
0.03
15.31%
0.01
74.81%
0.01
14.67%
0.02
116.44%
interest coverage
16.20
-
30.63
89.09%
147.63
382.01%
272.23
84.40%
90.54
66.74%
57.94
36.01%
-4.24
107.33%
25.26
695.13%
29.89
18.32%
30.24
1.17%
19.98
33.92%
interest debt per share
6.08
-
2.99
50.78%
0.22
92.64%
0.09
59.53%
5.89
6,510.84%
6.07
3.06%
20.42
236.52%
18.63
8.74%
18.23
2.14%
18.29
0.34%
15.28
16.49%
inventory turnover
2.75
-
1.88
31.50%
0.85
54.87%
0.73
14.35%
0.98
34.75%
1.97
100.83%
1.26
36.00%
1.25
0.75%
1.31
4.50%
1.44
10.13%
2.30
60.14%
invested capital
0.22
-
0.10
54.45%
0.00
96.63%
0.12
-
0.09
24.63%
0.31
241.00%
0.24
22.93%
0.20
14.24%
0.17
17.47%
0.12
29.87%
market cap
5.66B
-
6.24B
10.17%
7.20B
15.48%
6.28B
12.80%
6.51B
3.62%
4.74B
27.23%
3.86B
18.56%
6.71B
73.91%
9.70B
44.61%
12.65B
30.42%
10.93B
13.63%
net current asset value
125.76M
-
355.36M
182.58%
690.54M
94.32%
961.40M
39.22%
670.30M
30.28%
1.16B
72.40%
731.50M
36.70%
947.40M
29.51%
1.11B
17.52%
2.13B
91.53%
2.37B
11.08%
net debt to ebitda
0.02
-
-0.50
2,134.66%
-1.18
136.55%
-0.96
18.66%
-0.44
54.40%
-0.51
15.72%
-0.92
82.10%
0.09
109.88%
-0.15
268.91%
-0.16
6.17%
-0.37
123.63%
net income per share
3.49
-
7.06
102.50%
14.17
100.68%
16.29
15.03%
9.50
41.71%
13.54
42.61%
-2.39
117.61%
11.65
588.17%
10.60
9.02%
15.98
50.84%
19.81
23.96%
operating cash flow per share
8.49
-
7.37
13.17%
8.32
12.84%
14.69
76.59%
10.78
26.66%
17.89
66.04%
-4.72
126.36%
17.10
462.47%
13.32
22.08%
17.64
32.38%
19.68
11.57%
payables turnover
19.55
-
18.00
7.94%
9.20
48.86%
8.98
2.47%
12.58
40.20%
8.60
31.64%
11.88
38.10%
26.37
121.96%
32.24
22.27%
35.78
10.99%
45.98
28.51%
receivables turnover
8.84
-
7.94
10.23%
7.60
4.26%
7.45
1.94%
5.81
22.09%
9.26
59.54%
9.57
3.29%
9.42
1.52%
8.48
9.99%
8.79
3.57%
8.35
5.01%
research and ddevelopement to revenue
0.27
-
0.19
29.76%
0.17
11.17%
0.09
44.79%
0.15
66.12%
0.22
43.36%
0.82
271.25%
0.24
70.46%
0.32
32.88%
0.17
47.96%
0.18
5.12%
return on tangible assets
0.08
-
0.18
117.77%
0.30
64.86%
0.31
3.04%
0.15
52.65%
0.18
23.69%
-0.03
115.26%
0.12
515.06%
0.09
19.62%
0.12
30.55%
0.14
15.19%
revenue per share
22.31
-
26.75
19.91%
31.86
19.14%
36.50
14.56%
39.21
7.42%
37.42
4.57%
33.08
11.61%
33.56
1.45%
37.54
11.86%
42.56
13.36%
46.83
10.05%
roe
0.13
-
0.27
100.78%
0.41
51.60%
0.38
5.92%
0.20
48.12%
0.21
6.27%
-0.04
117.79%
0.15
503.43%
0.12
20.74%
0.15
26.16%
0.16
8.52%
roic
0.12
-
0.25
117.75%
0.27
8.42%
0.38
41.25%
0.19
50.97%
0.21
9.36%
-0.03
115.90%
0.11
448.37%
0.09
17.92%
0.13
43.11%
0.14
2.28%
sales general and administrative to revenue
0.23
-
0.24
5.25%
0.15
40.59%
0.15
6.08%
0.13
17.58%
0.19
49.75%
0.25
30.82%
0.24
3.98%
0.21
10.01%
0.17
20.99%
shareholders equity per share
26.05
-
26.27
0.86%
34.77
32.38%
42.52
22.26%
47.77
12.35%
64.11
34.20%
63.48
0.98%
76.81
21.01%
88.17
14.78%
105.42
19.56%
120.42
14.23%
stock based compensation to revenue
0.29
-
0.15
48.64%
0.19
29.63%
0.01
96.04%
0.04
462.90%
-0.02
138.07%
0.03
293.22%
0.11
252.40%
0.08
25.59%
0.06
32.88%
0.02
69.54%
tangible asset value
1.29B
-
1.24B
4.19%
1.57B
27.11%
1.83B
16.36%
2.06B
12.46%
2.62B
27.31%
2.62B
0.16%
3.24B
23.45%
3.91B
20.92%
4.75B
21.41%
5.87B
23.53%
tangible book value per share
25.76
-
25.66
0.41%
34.16
33.13%
41.74
22.21%
46.73
11.95%
60.18
28.78%
59.87
0.52%
73.24
22.34%
87.18
19.03%
104.44
19.81%
118.12
13.09%
working capital
221.34M
-
469.89M
112.29%
834.51M
77.60%
1.09B
30.89%
1.00B
8.16%
1.49B
48.66%
1.40B
6.03%
1.84B
31.57%
2.02B
9.45%
3.04B
50.49%
2.75B
9.57%

All numbers in USD (except ratios and percentages)